Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium

Trials

Volumn 10, Issue , 2009, Pages

  Tang, Ai Wei ^a   Alfirevic, Zarko ^a   Turner, Mark A ^a   Drury, Jo ^a   Quenby, Siobhan ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREDNISOLONE;

ADULT; ARTICLE; BIRTH RATE; CELL COUNT; CLINICAL PROTOCOL; CLINICAL TRIAL; COHORT ANALYSIS; CONCEPTION; CONGENITAL DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEASIBILITY STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC RECURRENT MISCARRIAGE; KARYOTYPE; LIVE BIRTH; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PILOT STUDY; POSTNATAL CARE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; STILLBIRTH; UTERUS; DRUG EFFECT; IMMUNOLOGY; METHODOLOGY; PREGNANCY; RECURRENT ABORTION; STATISTICS;

ABORTION, HABITUAL; CLINICAL PROTOCOLS; DOUBLE-BLIND METHOD; ENDOMETRIUM; FEMALE; HUMANS; KILLER CELLS, NATURAL; PREDNISOLONE; PREGNANCY; RESEARCH DESIGN; STATISTICS AS TOPIC; UTERUS;

EID: 71549163457     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-10-102     Document Type: Article

References (32)

1. Rai R, Regan L. Recurrent Miscarriage. Lancet 2006, 368:601-611. 10.1016/S0140-6736(06)69204-0, 16905025.
2. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 2002, 8:463-481. 10.1093/humupd/8.5.463, 12398226.
3. Quenby SM, Farquharson RG. Predicting recurring miscarriage: What is important?. Obstet Gynaecol 1993, 82:132-138.
4. Royal College of Obstetricians and Gynaecologists The investigation and treatment of couples with recurrent miscarriage. Guideline No. 17 2003, London: RCOG.
5. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006, 2:CD000112.
6. Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005, 26:44-62. 10.1210/er.2003-0021, 15689572.
7. King A, Balendran N, Woodling P, Carter NP, Loke YW. CD3- leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Developmental Immunology 1991, 1:169-190. 2275834, 1726555, 10.1155/1991/83493.
8. Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Repro 1991, 6:791-798.
9. Nagler A, Lanier LL, Cwiria S, Phillips JH. Comparative studies of human FcRIII-positive and negative natural killer cells. J of Immunology 1989, 143:3183-3191.
10. Moffett-King A. Natural Killer cells and pregnancy. Nat Rev Immunol 2002, 2:656-663. 10.1038/nri886, 12209134.
11. Bulmer JN, Lash GE. Human uterine natural killer cells: a reappraisal. Mol Immunol 2005, 42:511-521. 10.1016/j.molimm.2004.07.035, 15607807.
12. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992, 80:283-285.
13. Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003, 162:115-125. 1851128, 12507895.
14. Quenby S, Nik H, Innes B, Lash G, Turner M, Drury J, Bulmer J. Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Human Repro 2009, 24:45-54.
15. Lédée N, Chaouat G, Serazin V, Lombroso R, Dubanchet S, Oger P, Louafi N, Ville Y. Endometrial vascularity by three-dimensional power Doppler ultrasound and cytokines: a complementary approach to assess uterine receptivity. J Reprod Immunol 2008, 77:57-62. 10.1016/j.jri.2007.07.006, 17961712.
16. Clifford K, Flanagan AM, Regan L. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999, 14:2727-2730. 10.1093/humrep/14.11.2727, 10548610.
17. Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, Vince G. Pre-implantation endometrial leukocytes in woman with recurrent miscarriage. Hum Repro 1999, 14:2386-2391.
18. Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril 2005, 84:980-984. 10.1016/j.fertnstert.2005.05.012, 16213853.
19. Tuckerman E, Laird SM, Prakash A, Li TC. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Repro 2007, 22:2208-2213.
20. Shimada S, Kato EH, Morikawa M, Iwabuchi K, Nishida R, Kishi R, Onoé K, Minakami H, Yamada H. No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 2004, 19:1018-1024. 10.1093/humrep/deh159, 15033955.
21. Michimata T, Ogasawara MS, Tsuda H, Suzumori K, Aoki K, Sakai M, Fujimura M, Nagata K, Nakamura M, Saito S. Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol 2002, 47:196-202. 10.1034/j.1600-0897.2002.01048.x, 12069386.
22. Emmer PM, Steegers EA, Kerstens HM, Bulten J, Nelen WL, Boer K, Joosten I. Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Hum Reprod 2002, 17:1072-1080. 10.1093/humrep/17.4.1072, 11925408.
23. Quack KC, Vassiliadou N, Pudney J, Anderson DJ, Hill JA. Leukocyte activation in the decidua of chromosomally normal and abnormal fetuses from women with recurrent abortion. Hum Reprod 2001, 16:949-955. 10.1093/humrep/16.5.949, 11331643.
24. Henderson TA, Saunders PT, Moffett-King A. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab 2003, 88:440-449. 10.1210/jc.2002-021174, 12519888.
25. Addison RS, Maguire DJ, Mortimer RH, Roberts MS, Cannell GR. Pathway and kinetics of prednisolone metabolism in the human placenta. J Steroid Biochem Mol Biol 1993, 44:315-320. 10.1016/0960-0760(93)90093-C, 8461264.
26. Quenby S, Farquharson R, Young M, Vince G. Successful pregnancy outcome following 19 consecutive miscarriages: case report. Hum Reprod 2003, 18:2562-2564. 10.1093/humrep/deg502, 14645171.
27. Drury JA, Nik H, van Oppenraaj R, Turner MA, Quenby S. Endometrial cell counts in recurrent miscarriage: A comparison of counting methods. Placenta 2007, 28:A36.
28. Nelson-Piercy C. Asthma in pregnancy. Thorax 2001, 56:325-328. 1746013, 11254828, 10.1136/thorax.56.4.325.
29. Ostensen M. Drugs in pregnancy. Rheumatological disorders. Best Pract Res Clin Obstet Gynaecol 2001, 15:953-969. 10.1053/beog.2001.0240, 11800535.
30. Nelson-Piercy C, Fayers P, de Swiet M. Randomised, double-blind, placebo-controlled trial of corticosteroids for the treatment of hyperemesis gravidarum. BJOG 2001, 108:9-15. 10.1016/S0306-5456(00)00017-6, 11213010.
31. Miller NM, Williamson C, Fisk NM, Glover V. Infant cortisol response after prolonged antenatal prednisolone treatment. BJOG 2004, 111:1471-1474. 10.1111/j.1471-0528.2004.00288.x, 15663140.
32. CONSORT Statement Website. , http://www.consort-statement.org/